Concepedia

Mette Kruse Klausen

MK

Statistics

Publications

5

Citations

374

H-Index

5

Active since

2018

Affiliations

University of Copenhagen(Current)

Novo Nordisk Foundation

Copenhagen University Hospital

Steno Diabetes Centers

National Institutes of Health

Mette Kruse Klausen is an author at University of Copenhagen specializing in medicine, pharmacology, and substance use disorders.

ORCID

Top concepts

Publications per year

2018–2024

5

Publications

5

Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial

Mette Kruse Klausen, Mathias E. Jensen, Marco Møller et al. · JCI Insight · 2022 · 189 citations · Full text

GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders

Lorenzo Leggio, Christian S. Hendershot, Mehdi Farokhnia et al. · Nature Medicine · 2023 · 73 citations · Full text

, , +14

Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial

Kerstin K Antonsen, Mette Kruse Klausen, Amanda Brunchmann et al. · BMJ Open · 2018 · 42 citations · Full text

Effect of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide on alcohol consumption in alcohol-preferring male vervet monkeys

Anders Fink‐Jensen, Gitta Wörtwein, Mette Kruse Klausen et al. · Psychopharmacology · 2024 · 37 citations · Full text

Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent

Mathias E. Jensen, Aurelio Galli, Morgane Thomsen et al. · Neurochemistry International · 2020 · 33 citations · Full text

, , +4

1–5 of 5